Books

When Did Biotech Investors Get So Sophisticated? will Febbo, Bioworld Perspectives Contributing Writer, Comments on How Hedge Funds and New Research Models are Changing the Rules of Biotech Investment (Hedge Funds) When Did Biotech Investors Get So Sophisticated? will Febbo, Bioworld Perspectives Contributing Writer, Comments on How Hedge Funds and New Research Models are Changing the Rules of Biotech Investment (Hedge Funds)
2008
Ukraine: Big Potential, Risky Environment: Sarah Carey, Senior Partner at International Law Firm Squire, Sanders & Dempsey LLP, and Co-Ordinator of the Firm's CIS Practice, Discusses the Positive and Negative Aspects of the Pharmaceutical Business in Ukraine (Country Survey) (Report) Ukraine: Big Potential, Risky Environment: Sarah Carey, Senior Partner at International Law Firm Squire, Sanders & Dempsey LLP, and Co-Ordinator of the Firm's CIS Practice, Discusses the Positive and Negative Aspects of the Pharmaceutical Business in Ukraine (Country Survey) (Report)
2008
Communicating Locally: There are Very Real Local Differences in Marketing Pharma Products Around the World. Gary Muddyman, CEO and Managing Director of Conversis and Member of the Globalization and Localization Association (GALA), Discusses the Importance of Cultural Customization for Foreign Language Communication and Marketing Materials in the Global Pharmaceutical Industry (Marketing) Communicating Locally: There are Very Real Local Differences in Marketing Pharma Products Around the World. Gary Muddyman, CEO and Managing Director of Conversis and Member of the Globalization and Localization Association (GALA), Discusses the Importance of Cultural Customization for Foreign Language Communication and Marketing Materials in the Global Pharmaceutical Industry (Marketing)
2009